PIIS2405844023043578.pdf (1.96 MB)
Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
journal contribution
submitted on 2023-07-04, 06:53 and posted on 2023-07-04, 12:17 authored by Elias Tayar, Ryan Isber, Nidal IsberLong COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms.
We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive antiviral treatment.
Other Information
Published in: Heliyon
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: http://dx.doi.org/10.1016/j.heliyon.2023.e17149
Funding
Open Access funding provided by the Qatar National Library
History
Language
- English
Publisher
Cell PressPublication Year
- 2023
License statement
This Item is licensed under the Creative Commons Attribution 4.0 International LicenseInstitution affiliated with
- Hamad Medical Corporation
